Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Artificial Intelligence | 16 | 2026 | 59 | 4.180 |
Why?
|
| Algorithms | 18 | 2025 | 241 | 3.130 |
Why?
|
| Image Interpretation, Computer-Assisted | 10 | 2014 | 60 | 3.070 |
Why?
|
| Ultrasonography, Interventional | 8 | 2013 | 8 | 2.670 |
Why?
|
| Coronary Artery Disease | 9 | 2026 | 17 | 2.480 |
Why?
|
| Image Processing, Computer-Assisted | 8 | 2016 | 97 | 2.310 |
Why?
|
| Imaging, Three-Dimensional | 8 | 2016 | 68 | 2.180 |
Why?
|
| Pattern Recognition, Automated | 8 | 2015 | 57 | 2.060 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2026 | 26 | 1.640 |
Why?
|
| Machine Learning | 5 | 2025 | 35 | 1.270 |
Why?
|
| Brain | 6 | 2016 | 195 | 1.260 |
Why?
|
| Image Enhancement | 8 | 2013 | 46 | 1.220 |
Why?
|
| Primary Health Care | 5 | 2024 | 46 | 1.190 |
Why?
|
| Coronary Vessels | 5 | 2026 | 27 | 1.120 |
Why?
|
| Humans | 28 | 2026 | 4936 | 1.120 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 4 | 2010 | 8 | 1.100 |
Why?
|
| Sensitivity and Specificity | 14 | 2018 | 126 | 1.080 |
Why?
|
| Animals | 18 | 2020 | 1711 | 0.960 |
Why?
|
| Gene Expression | 3 | 2014 | 49 | 0.920 |
Why?
|
| Typhus, Endemic Flea-Borne | 1 | 2025 | 2 | 0.900 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2025 | 3 | 0.900 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2025 | 3 | 0.900 |
Why?
|
| Reproducibility of Results | 13 | 2013 | 318 | 0.880 |
Why?
|
| Neurons | 2 | 2016 | 109 | 0.860 |
Why?
|
| Zebrafish | 4 | 2020 | 20 | 0.840 |
Why?
|
| Gene Expression Profiling | 3 | 2012 | 48 | 0.830 |
Why?
|
| Aorta | 2 | 2016 | 8 | 0.780 |
Why?
|
| Cardiovascular Diseases | 2 | 2025 | 43 | 0.770 |
Why?
|
| Embryo, Nonmammalian | 3 | 2014 | 18 | 0.720 |
Why?
|
| Technology | 1 | 2022 | 6 | 0.720 |
Why?
|
| Risk Assessment | 3 | 2026 | 44 | 0.690 |
Why?
|
| Calcinosis | 2 | 2010 | 5 | 0.640 |
Why?
|
| Diffusion of Innovation | 1 | 2020 | 3 | 0.630 |
Why?
|
| Family Practice | 1 | 2020 | 19 | 0.610 |
Why?
|
| Microscopy, Confocal | 2 | 2020 | 49 | 0.600 |
Why?
|
| Female | 12 | 2026 | 2523 | 0.600 |
Why?
|
| Face | 2 | 2011 | 19 | 0.600 |
Why?
|
| Models, Theoretical | 2 | 2016 | 75 | 0.580 |
Why?
|
| Ultrasonography | 2 | 2016 | 20 | 0.570 |
Why?
|
| Models, Biological | 2 | 2011 | 124 | 0.550 |
Why?
|
| Vascular Calcification | 3 | 2026 | 6 | 0.540 |
Why?
|
| Decision Trees | 1 | 2017 | 9 | 0.540 |
Why?
|
| Patient Compliance | 1 | 2017 | 17 | 0.540 |
Why?
|
| Cancer Survivors | 1 | 2017 | 14 | 0.530 |
Why?
|
| Male | 11 | 2026 | 2491 | 0.530 |
Why?
|
| Databases, Factual | 2 | 2015 | 26 | 0.520 |
Why?
|
| Time-Lapse Imaging | 2 | 2020 | 9 | 0.490 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 96 | 0.480 |
Why?
|
| Microscopy | 1 | 2016 | 35 | 0.470 |
Why?
|
| Nerve Tissue Proteins | 2 | 2007 | 34 | 0.460 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2015 | 3 | 0.460 |
Why?
|
| Exercise | 1 | 2017 | 173 | 0.450 |
Why?
|
| Mice | 6 | 2016 | 685 | 0.440 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2026 | 39 | 0.440 |
Why?
|
| Computational Biology | 1 | 2014 | 32 | 0.430 |
Why?
|
| Swine | 5 | 2016 | 50 | 0.430 |
Why?
|
| Middle Aged | 7 | 2026 | 967 | 0.430 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 19 | 0.400 |
Why?
|
| Coronary Stenosis | 1 | 2013 | 1 | 0.390 |
Why?
|
| Echocardiography | 1 | 2013 | 9 | 0.390 |
Why?
|
| Rabbits | 4 | 2016 | 39 | 0.370 |
Why?
|
| Anatomy, Artistic | 1 | 2012 | 1 | 0.360 |
Why?
|
| Arteries | 1 | 2012 | 2 | 0.360 |
Why?
|
| Atlases as Topic | 1 | 2012 | 2 | 0.360 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 3 | 0.360 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2012 | 7 | 0.360 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 11 | 0.350 |
Why?
|
| Aged | 6 | 2026 | 703 | 0.340 |
Why?
|
| Facial Expression | 2 | 2011 | 10 | 0.340 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 24 | 0.340 |
Why?
|
| Radiographic Image Enhancement | 2 | 2006 | 8 | 0.290 |
Why?
|
| Artifacts | 1 | 2008 | 10 | 0.290 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2008 | 28 | 0.290 |
Why?
|
| Predictive Value of Tests | 4 | 2026 | 30 | 0.280 |
Why?
|
| Electrocardiography | 1 | 2008 | 13 | 0.280 |
Why?
|
| Animals, Genetically Modified | 3 | 2020 | 12 | 0.280 |
Why?
|
| Automation | 3 | 2012 | 13 | 0.260 |
Why?
|
| Blood | 1 | 2007 | 4 | 0.260 |
Why?
|
| Biometry | 1 | 2007 | 31 | 0.260 |
Why?
|
| Risk Factors | 3 | 2025 | 159 | 0.250 |
Why?
|
| Pericardium | 1 | 2006 | 3 | 0.240 |
Why?
|
| Quality of Health Care | 1 | 2026 | 5 | 0.240 |
Why?
|
| Diabetes Complications | 1 | 2026 | 5 | 0.240 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2026 | 10 | 0.240 |
Why?
|
| Adipose Tissue | 1 | 2006 | 18 | 0.240 |
Why?
|
| Kidney Failure, Chronic | 1 | 2025 | 2 | 0.230 |
Why?
|
| Kidney Transplantation | 1 | 2025 | 3 | 0.230 |
Why?
|
| Waiting Lists | 1 | 2025 | 3 | 0.230 |
Why?
|
| Patient Dropouts | 1 | 2025 | 4 | 0.230 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2026 | 20 | 0.230 |
Why?
|
| Referral and Consultation | 1 | 2025 | 4 | 0.230 |
Why?
|
| Heart Failure | 1 | 2026 | 30 | 0.230 |
Why?
|
| Health Care Costs | 1 | 2025 | 12 | 0.230 |
Why?
|
| Fatty Liver | 1 | 2025 | 7 | 0.230 |
Why?
|
| Diagnosis, Differential | 1 | 2025 | 14 | 0.230 |
Why?
|
| Calcium | 1 | 2025 | 31 | 0.220 |
Why?
|
| Atherosclerosis | 1 | 2025 | 16 | 0.220 |
Why?
|
| Infant | 1 | 2025 | 78 | 0.220 |
Why?
|
| Computer Simulation | 3 | 2011 | 161 | 0.210 |
Why?
|
| Electronic Health Records | 2 | 2024 | 16 | 0.210 |
Why?
|
| Child, Preschool | 1 | 2025 | 180 | 0.210 |
Why?
|
| Data Interpretation, Statistical | 2 | 2013 | 8 | 0.190 |
Why?
|
| Clinical Decision-Making | 1 | 2022 | 4 | 0.180 |
Why?
|
| United States | 4 | 2026 | 495 | 0.180 |
Why?
|
| Child | 1 | 2025 | 627 | 0.180 |
Why?
|
| Communication | 1 | 2022 | 28 | 0.180 |
Why?
|
| Adolescent | 1 | 2025 | 758 | 0.170 |
Why?
|
| Models, Statistical | 2 | 2012 | 62 | 0.170 |
Why?
|
| Intersectoral Collaboration | 1 | 2020 | 2 | 0.160 |
Why?
|
| Automation, Laboratory | 2 | 2010 | 7 | 0.160 |
Why?
|
| Embryonic Development | 1 | 2020 | 13 | 0.160 |
Why?
|
| Scattering, Radiation | 2 | 2011 | 18 | 0.160 |
Why?
|
| Texas | 2 | 2010 | 190 | 0.150 |
Why?
|
| Support Vector Machine | 1 | 2018 | 2 | 0.150 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 21 | 0.140 |
Why?
|
| Quality of Life | 1 | 2017 | 87 | 0.120 |
Why?
|
| Cell Wall | 1 | 2016 | 10 | 0.120 |
Why?
|
| Tissue Distribution | 2 | 2007 | 26 | 0.120 |
Why?
|
| Optical Imaging | 1 | 2016 | 17 | 0.120 |
Why?
|
| Anura | 1 | 2016 | 11 | 0.120 |
Why?
|
| Chickens | 1 | 2016 | 22 | 0.120 |
Why?
|
| Drosophila | 1 | 2016 | 25 | 0.120 |
Why?
|
| Dendrites | 1 | 2015 | 3 | 0.120 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2015 | 8 | 0.120 |
Why?
|
| Software | 2 | 2014 | 57 | 0.120 |
Why?
|
| Prognosis | 2 | 2025 | 60 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2025 | 83 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 2 | 2007 | 184 | 0.110 |
Why?
|
| Longitudinal Studies | 2 | 2026 | 137 | 0.110 |
Why?
|
| Teratogens | 1 | 2014 | 1 | 0.110 |
Why?
|
| Egg Yolk | 1 | 2014 | 2 | 0.110 |
Why?
|
| Anatomic Landmarks | 1 | 2014 | 1 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2026 | 262 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 176 | 0.100 |
Why?
|
| Internationality | 1 | 2013 | 6 | 0.100 |
Why?
|
| Reference Values | 1 | 2013 | 26 | 0.100 |
Why?
|
| Vasa Vasorum | 1 | 2012 | 1 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 197 | 0.090 |
Why?
|
| Contrast Media | 1 | 2012 | 8 | 0.090 |
Why?
|
| Markov Chains | 1 | 2012 | 19 | 0.090 |
Why?
|
| Absorption | 1 | 2011 | 3 | 0.080 |
Why?
|
| Normal Distribution | 1 | 2011 | 5 | 0.080 |
Why?
|
| Physics | 1 | 2011 | 5 | 0.080 |
Why?
|
| Chromosomes | 1 | 2011 | 3 | 0.080 |
Why?
|
| Inflammation | 1 | 2011 | 57 | 0.080 |
Why?
|
| Radio Waves | 1 | 2011 | 48 | 0.080 |
Why?
|
| Models, Cardiovascular | 1 | 2010 | 19 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2010 | 48 | 0.080 |
Why?
|
| Heart | 1 | 2010 | 48 | 0.080 |
Why?
|
| Movement | 1 | 2010 | 52 | 0.080 |
Why?
|
| Photons | 1 | 2008 | 8 | 0.070 |
Why?
|
| Subtraction Technique | 1 | 2006 | 9 | 0.060 |
Why?
|
| Comorbidity | 1 | 2026 | 47 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2026 | 51 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2026 | 111 | 0.060 |
Why?
|
| Medicare Part C | 1 | 2026 | 32 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2026 | 78 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2024 | 3 | 0.050 |
Why?
|
| Physician-Patient Relations | 1 | 2024 | 9 | 0.050 |
Why?
|
| Health Facilities | 1 | 2021 | 2 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 20 | 0.040 |
Why?
|
| Policy | 1 | 2021 | 3 | 0.040 |
Why?
|
| Hospitalization | 1 | 2021 | 38 | 0.040 |
Why?
|
| Pandemics | 1 | 2021 | 73 | 0.040 |
Why?
|
| Adult | 1 | 2025 | 1567 | 0.040 |
Why?
|
| Agar | 1 | 2016 | 5 | 0.030 |
Why?
|
| Metronidazole | 1 | 2016 | 15 | 0.030 |
Why?
|
| Culture Media | 1 | 2016 | 18 | 0.030 |
Why?
|
| Vancomycin | 1 | 2016 | 28 | 0.030 |
Why?
|
| Aminoglycosides | 1 | 2016 | 17 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2016 | 37 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 96 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2014 | 22 | 0.030 |
Why?
|